MedTrace Logo

Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.

NCT05738460 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-02-22

No results posted yet for this study

Summary

This study is planned to be recruited in two hospitals in South China, Zhujiang Hospital of Southern Medical University and Zhongshan Boai Hospital Recruit participants, plan to recruit obstetrics and child health departments in study hospitals, meet inclusion and discharge criteria 1\~3 infants, a total of 360, recruited by Pearl River Hospital of Southern Medical University and Zhongshan Boai Hospital 180 people each.

Conditions

  • Healthy
  • Metabolism
  • Microbiome

Interventions

DRUG

antibiotics

Reproductive tract GBS colonization group of mothers during pregnancy，Use of antibiotics

Sponsors & Collaborators

  • Zhongshan Bo Ai Hospital

    collaborator OTHER

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Qian Wang · Southern Medical University, China

Eligibility

Min Age
37 Weeks
Max Age
41 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-23
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738460 on ClinicalTrials.gov